Stay updated on Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-15T20:55:43.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-08T20:56:48.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Access to the study record NCT02697630 (PEMDAC) on ClinicalTrials.gov now renders a 403 Forbidden error, replacing the previous study content. As a result, the study overview, eligibility criteria, locations, and results are not accessible to users.
    Difference
    17%
    Check dated 2026-09-24T21:34:05.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0 in place of Revision: v3.6.6, indicating a new build/version of the page.
    Difference
    0.1%
    Check dated 2026-09-17T21:39:38.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page revision was bumped from v3.6.4 to v3.6.5. This indicates a minor update to the page build rather than changes to study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-08-06T20:11:32.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, signaling a new version of the entry; this reflects a minor update to the page metadata rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-07-23T12:09:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page.